Alkem Laboratories Limited
ALKEM
Clasificación en acciones
#2813
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Precio por acción
$55.19
Capitalización bursátil
$6.60B
Cambio (1 día)
-0.06%
Cambio (1 año)
-12.43%
País
IN
Comercio Alkem Laboratories Limited (ALKEM)
Categoría
Healthcare
Ratio P/B de Alkem Laboratories Limited (ALKEM)
Ratio P/B al October 2026 TTM: 4.31
Según los informes financieros más recientes y el precio de las acciones de Alkem Laboratories Limited, el ratio P/B actual (TTM) es 4.31. Al final de 2024, el ratio P/B era 5.81.
Historial del ratio P/B de Alkem Laboratories Limited desde 2010 hasta 2026
Ratio P/B al final de cada año
| Año | Ratio P/B | Cambiar |
|---|---|---|
| 2026 (TTM) | 4.31 | -10.49% |
| 2025 | 4.82 | -16.94% |
| 2024 | 5.81 | 29.38% |
| 2023 | 4.49 | -10.43% |
| 2022 | 5.01 | 11.63% |
| 2021 | 4.49 | -0.54% |
| 2020 | 4.51 | 17.52% |
| 2019 | 3.84 | -18.59% |
| 2018 | 4.72 | -20.04% |
| 2017 | 5.90 | 34.33% |
| 2016 | 4.39 | -20.25% |
| 2015 | 5.51 | -11.47% |
| 2014 | 6.22 | -10.59% |
| 2013 | 6.96 | -19.73% |
| 2012 | 8.67 | -25.08% |
| 2011 | 11.57 | -15.57% |
| 2010 | 13.71 | 0.00% |
Ratio P/B de empresas similares o competidoras
| Empresa | Ratio P/B | Diferencia del ratio P/B | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 16.85% |
IN
|
